State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSE Arca · ETF
$67.06-2.22%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $270.45M
- Volume
- 96,326
- 52-week high
- —
- 52-week low
- —
- Open
- $68.76
- Day high
- $69.04
- Day low
- $67.00
Top holdings
| Holding | Name | Weight |
|---|---|---|
| OGN | Organon & Co Ordinary Shares | 3.78% |
| CORT | Corcept Therapeutics Inc | 3.74% |
| DFTX | Definium Therapeutics Inc Ordinary Shares | 3.09% |
| LQDA | Liquidia Corp Ordinary Shares | 2.91% |
| MBX | MBX Biosciences Inc | 2.72% |
| AXSM | Axsome Therapeutics Inc | 2.67% |
| JAZZ | Jazz Pharmaceuticals PLC | 2.31% |
| RPRX | Royalty Pharma PLC Class A | 2.17% |
| ALMS | Alumis Inc | 2.14% |
| ATAI | AtaiBeckley Inc | 2.13% |
About State Street SPDR S&P Pharmaceuticals ETF
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.